ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: musculoskeletal disease

Call for USBJD Young Investigators Applicants

  |  

The Research Committee of the United States Bone and Joint Decade (USBJD) has launched a series of workshops to provide early-career clinical investigators with an opportunity to work with experienced researchers in rheumatology, and to assist them in securing funding and learning other survival skills required for pursuing an academic career.

ACR Image Competition 2025 Results, Part 1—Best Overall

  |  

Every year, the ACR conducts a case-based image competition. Images are submitted for peer review. The winning images are displayed at ACR Convergence and winners receive other benefits, as well. This year, the overall winning images were submitted by Madhuri Challa, MD, of Hyderabad, Telangana, India. Presentation These are the representative clinical and radiological images…

The Great Debate: Ultrasound vs. Temporal Artery Biopsy in Giant Cell Arteritis

Michael Cammarata, MD, RhMSUS  |  

In the ACR Convergence 2025 session, Great Debate: Ultrasound vs. Temporal Artery Biopsy in Giant Cell Arteritis, two vasculitis experts went head to head to determine the ideal first test in the diagnosis GCA: ultrasound or biopsy.

Insights into SLE & Lupus Nephritis From the 2025 Review Course

Jason Liebowitz, MD  |  

Review expert strategies & clinical pearls for managing SLE & lupus nephritis. Get therapeutic updates from the ACR’s 2025 Review Course.

Belimumab Promising for Children with Lupus Nephritis

  |  

In late July 2022, the U.S. Food & Drug Administration (FDA) approved belimumab (Benlysta) for the treatment of children with active lupus nephritis aged 5 to 17 years old receiving standard therapy.1 Despite recent advances in treatment options for patients with systemic lupus erythematosus (SLE), those with kidney involvement may develop endstage renal disease and…

Neutrophilic Inflammation in Spondyloarthritis

Michael Cammarata, MD  |  

CHICAGO—In the basic science session, Beyond NETs: Alternative Roles of Neutrophils in Spondyloarthritis, neutrophils are explored as a common pathophysiologic thread among the spondyloarthropathies. In this two-part talk, Dennis McGonagle, PhD, professor of investigative rheumatology at the Leeds Institute of Rheumatic and Musculoskeletal Medicine at St James Hospital, Leeds, England, opens by examining the role…

New Rheumatoid Arthritis Risk Stratification Criteria Released

  |  

New EULAR/ACR criteria help stratify RA risk in patients with arthralgia. Learn how these criteria guide earlier interventions & improve trial rigor.

JIA: The Transition to Adult Care

  |  

Experts addressed considerations for how to aid patients with juvenile idiopathic arthritis (JIA) in their transition to adult care, specifically highlighting clinical pearls for those with pediatric uveitis and TMJ arthritis.